Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Gestational Diabetes Mellitus and its risks to the baby

Eliminated cells initiate a protective mechanism

Porcine Epidemic Diarrhoea Virus – Highly Infectious pathogen

Gestational Diabetes Mellitus and its risks to the baby
  • BiotechToday
  • World

Gestational Diabetes Mellitus and its risks to the baby

bioxone July 13, 2021July 12, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University

During pregnancy, several different hormones are produced in the body like human placental lactogen, cortisol, and progesterone for the maintenance of a healthy pregnancy. Over time the amount of these hormones increases in the body and they start resisting the effects of insulin, the hormone that is responsible for maintaining the blood sugar level. Insulin is responsible for moving the glucose from the bloodstream into the cells. During pregnancy, glucose needs to be provided to the fetus for its growth and development. So, the body becomes slightly insulin resistant so that the glucose stays in the bloodstream and gets transported to the fetus. 

What is gestational diabetes mellitus(GDM)?

Sometimes the insulin resistance becomes too strong and the blood glucose levels may rise abnormally. This can cause gestational diabetes. This condition typically develops during the 24th and 28th weeks of pregnancy. Although this condition is common and temporary if left untreated gestational diabetes raises the chances of developing type 2 diabetes in the future. If gestational diabetes is poorly managed it can also raise the child’s risk of developing type 2 diabetes later in life. Other complications include an overweight baby at the time of birth, preterm (early) birth, serious breathing difficulties, hypoglycemia, and stillbirth.

What is neonatal hypoglycemia?

Neonatal hypoglycemia occurs within 24 hours of birth. Hypoglycemia can bring about some serious and long-lasting neurological problems. Unfortunately, hypoglycemia is asymptomatic and does not have any specific symptoms. So, screening programs have been developed and widely accepted for the early development and management of hypoglycemia. These guidelines include early feeding, blood glucose monitoring, and regular assessment of clinical conditions. International Association of Diabetes and Pregnancy Study Group’s criteria to diagnose GDM led to more women being diagnosed with GDM, with consequently more babies monitored on a high-risk pathway for hypoglycemia. This has increased the workload on midwives. It has also led to the admission of healthy babies who might not need any special monitoring.

What was the study about?

In a study at a teaching hospital in South East England, the risk of neonatal hypoglycemia concerning maternal characteristics (age, BMI, ethnic background), treatment for diabetes during pregnancy, use of insulin infusion during pregnancy, etc. 

What did the researchers find?

The study found that the risk of neonatal hypoglycemia is not predictable from the maternal background and medication. The researchers found that in babies born to women with GDM without other risk factors for hypoglycemia if the first blood glucose is more than 2.6mmol/L further measurements are not required. All babies with hypoglycemia had blood glucose levels less than 2.6mmol/L. Using this 2.6mmol/L threshold, extended monitoring can be avoided for 60% of babies. With this information now, we should tailor postnatal care plans for babies born to mothers with gestational diabetes mellitus to avoid excess workload in NICUs, among midwives, and wastage of resources.

Also read: Liquid biopsy and droplet digital PCR help to detect Colorectal cancer
Source: Park, E.H.G., O’Brien, F., Seabrook, F. et al. Safe threshold of capillary blood glucose for predicting early future neonatal hypoglycaemia in babies born to mothers with gestational diabetes mellitus, an observational, retrospective cohort study. BMC Pregnancy Childbirth21, 499 (2021). https://doi.org/10.1186/s12884-021-03973-5

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

About the author: Vaishnavi is a master’s student at the Bioinformatics Centre, Savitribai Phule University. She is interested in protein folding mechanisms and wants to study them further. She loves travelling and eating ice cream. As a pastime, she likes to read, paint and scroll through social media. 

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged blood glucose Gestational diabetes hypoglycemia insulin neonatal care pregnancy Type 2 diabetes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Porcine Epidemic Diarrhoea Virus – Highly Infectious pathogen

bioxone July 13, 2021

Ananya Ghosal, MAKAUT (WB) Porcine epidemic diarrhoea virus (PEDV) is a highly infectious virus and has a high mortality rate in neonates. A vaccine’s goal is to co-assemble Nomo trimer spikes on PEDV membranes to enable host cell entry. The PEDV S protein’s immunogenicity in mice assessed using a silkworm-baculovirus expression vector system. Trimerized S […]

Porcine epidemic diarrhoea

Related Post

  • BiotechToday
  • World

COVID-19 vaccine in Immunocompromised individuals.

bioxone July 10, 2021July 9, 2021

Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?

bioxone October 24, 2020October 24, 2020

Ayooshi Mitra, Amity University, Kolkata The crucial mechanism for severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) infections initializes with the binding of the viral spike protein to angiotensin-converting enzyme II (ACE2) human receptor protein. In order to create a set of ACE2 variants optimized for affinity and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Ex-situ DNA synthesis accelerated

bioxone October 17, 2020October 16, 2020

Jayateerth S Bhavikatti, CSIR-National Chemical Laboratory, Pune. We have recently come across that the Nobel Prize for Chemistry 2020 is awarded to Emmanuelle Charpentier and Jennifer A. Doudna for developing CRISPR/Cas9 genetic scissors. This process requires guide RNA for cutting DNA at specific locations in the genome. Many techniques in molecular biology require template nucleotide […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy